Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,559 | -101,851 | -84,214 | -63,856 | 0 |
| Depreciation Amortization | 727 | 483 | 255 | 83 | 0 |
| Accounts receivable | -5,413 | -500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,905 | 897 | -799 | -459 | N/A |
| Other Working Capital | 75,363 | 91,005 | 47,944 | 89,227 | 0 |
| Other Operating Activity | 12,787 | -1,706 | 42,822 | 1,175 | 0 |
| Operating Cash Flow | $-36,190 | $-11,672 | $6,008 | $26,170 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -202,599 | -176,191 | -43,389 | -46,715 | N/A |
| PPE Investments | -9 | -9 | N/A | N/A | 0 |
| Investing Cash Flow | $-202,608 | $-176,200 | $-43,389 | $-46,715 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 106,000 | 106,000 | 106,000 | 91,000 | N/A |
| Common Stock Issued | 185,438 | 185,438 | N/A | N/A | N/A |
| Other Financing Activity | -2,037 | -1,057 | -1,031 | -459 | 0 |
| Financing Cash Flow | $289,401 | $290,381 | $104,969 | $90,541 | $0 |
| Exchange Rate Effect | -93 | N/A | 0 | 5 | 0 |
| Beginning Cash Position | 7,857 | 7,857 | 7,857 | 7,857 | 0 |
| End Cash Position | 58,367 | 110,366 | 75,445 | 77,858 | 0 |
| Net Cash Flow | $50,510 | $102,509 | $67,588 | $70,001 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,190 | -11,672 | 6,008 | 26,170 | 0 |
| Capital Expenditure | -9 | -9 | N/A | N/A | N/A |
| Free Cash Flow | -36,199 | -11,681 | 6,008 | 26,170 | 0 |